[Federal Register Volume 65, Number 100 (Tuesday, May 23, 2000)]
[Notices]
[Pages 33337-33338]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-12903]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: June 28, 2000.
    Time: 8 a.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Minority Institutions' Drug Abuse Research 
Development Program.
    Date: June 28, 2000.
    Time: 3 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Arlington, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, Msc 9547, Bethesda, MD 29089-2954, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: June 29-30, 2000.

[[Page 33338]]

    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street NW, Washington, DC 
20004.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development Research.
    Date: June 29, 2000.
    Time: 9 a.m. to 11 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Arlington, 1325 Wilson Blvd., Arlington, VA 22209.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: June 29-30, 2000.
    Time: 11 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW, Washington, DC 
20004.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1432.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers Review Committee.
    Date: June 29, 2000.
    Time: 6 p.m. to 7:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Aids Research Core Grants.
    Date: June 30, 2000.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Health Services Research.
    Date: June 30, 2000.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street NW, Washington, DC 
20004.
    Contact Person Susan L. Coyle, PhD, Chief, Clinical, 
Epidemiological and Applied Sciences Review Branch, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Treatment Research.
    Date: June 30, 2000.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW, Washington, DC 
20004.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 
(301) 435-1433.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: July 6-7, 2000.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Mark Swieter, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Program Projects.
    Date: July 10, 2000.
    Time: 10 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, 
MD 20814.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, Msc 9547, Bethesda, MD 29089-2954, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, The Next Generation of Drug Abuse Prevention 
Research.
    Date: July 13, 2000.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: William C. Grace, PhD, Deputy Director, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Microarray-Based Research On Drug Abuse.
    Date: July 17-18, 2000.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Hotel, 5151 Pooks Hill Road, Bethesda, MD 20814.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs. National Institute on Drug Abuse. 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Basic Behavioral, Cognitive, and Neurological 
Research: Applications to HIV/AIDS and Drug Abuse.
    Date: July 20, 2000.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel, 2121 P Street NW. Washington, DC 
20037.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9597, 
(301) 435-1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, HIV Therapy for Drug Users: Access, Adherence, 
Effectiveness.
    Date: July 21, 2000.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel 2121 P Street NW Washington, DC 
20037.
    Contact Person: Marina L. Volkov. PhD, Heath Scientist 
Administrator, Office of Extramural Program Review, National Institute 
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS).

    Dated: May 12, 2000.
LaVerne Y. Stringfiled,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-12903 Filed 5-22-00; 8:45 am]
BILLING CODE 4140-01-M